HighTower Advisors’s Korro Bio KRRO Stock Holding History

HighTower Advisors’s Portfolio KRRO Stock Details KRRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-641	Closed	-$615K	–	2729
2020 Q3	$615K	Sell	641 -1,496	-70%	-$1.61M	﹤0.01%	1477
2020 Q2	$2.48M	Buy	+2,137	New	+$1.93M	0.01%	728

Other funds holding KRRO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MICM

Matthews International Capital Management San Francisco, California $246M AUM 10.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

HighTower Advisors's KRRO Position: Q4 2020 in Review

HighTower Advisors sold out of Korro Bio (KRRO) in Q4 2020, closing a stake of 641 shares — an estimated $615K sold.

HighTower Advisors first reported a position in KRRO in Q2 2020 and held it in 2 quarters. The position peaked at $2.48M in Q2 2020. 100 funds tracked by Wall St. Rank hold KRRO as of Q4 2020.

HighTower Advisors reported no remaining Korro Bio position as of Q4 2020 after selling out during the quarter.
HighTower Advisors sold 641 Korro Bio shares in Q4 2020, an estimated $615K.
HighTower Advisors first reported a position in Korro Bio in Q2 2020 and held it in 2 quarters.
HighTower Advisors's Korro Bio position peaked at $2.48M in Q2 2020.
100 funds tracked by Wall St. Rank held Korro Bio as of Q4 2020.

Based on HighTower Advisors's 13F filing for Q4 2020, filed 10 Feb 2021.